Protagonist Therapeutics, Inc. (PTGX)
$154.72+0.26%Close
BUYBULL · day 53
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $10.0B
- Avg volume
- 657.3K
- Beta
- 1.79
- P/E (TTM)
- 127.02
- Short % float
- 14.37%
- Days to cover
- 14.2
- SI change
- -9.0%
- 1W
- -2.46%
- 1M
- +13.67%
- 3M
- +55.98%
- YTD
- +77.47%
- vs SPY 1W
- -1.27%
- vs SPY 1M
- +10.35%
- vs SPY 3M
- +53.59%
- vs SPY YTD
- +65.72%
Industry peers
FMP comparable companies · ranked by market cap
- KYMRBUYKymera Therapeutics, Inc.$10.0BBULLQ 27$121.50+1.04%
- IMVTBUYImmunovant, Inc.$9.2BBULLQ 30$44.35-2.37%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.69+0.11%
- ALKSSELLAlkermes plc$8.1BBEARQ 6$48.02+1.12%
- TGTXBUYTG Therapeutics, Inc.$7.7BRECOVERYQ 11$50.56+3.21%
- ACLXArcellx, Inc.$6.7B$115.07
- PTCTSELLPTC Therapeutics, Inc.$5.9BRECOVERYQ 19$70.52+1.78%
- AKROAkero Therapeutics, Inc.$4.5B$54.65
- VKTXSELLViking Therapeutics, Inc.$4.0BRECOVERYQ 23$34.36-1.95%
- NAMSSELLNewAmsterdam Pharma Company N.V.$3.2BRECOVERYQ 29$27.78-3.66%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…